Since 1989, ASBL Prométhéa has been organising yearly Caïus competitions aiming to reward sponsors in Wallonia and Brussels, which support projects, organisations and institutions in the field of culture and heritage. This support can be financial, logistical, material, technological or human in nature. Prométhéa encourages and facilitates meetings between the corporate milieu and the world of culture and heritage, and also guides businesses in their sponsorship strategies.
This year will be the first time the Caïus awards are granted in seven categories: business sponsorship, cultural sponsorship, social sponsorship, heritage sponsorship, first sponsorship, sponsorship tradition and innovation sponsorship.
Mithra Pharmaceuticals is receiving a Caïus cultural sponsorship award for its “bold long-term commitment, which guarantees the quality and sustainability of the “Jazz à Liège” music festival, chaired this year by Gilles Ledure, Managing Director of Flagey.
Mithra Jazz à Liège
Mithra makes it a point of honour to broaden the horizons of its actions at both national and international level. The long-term partnership between Mithra Pharmaceuticals and “Jazz à Liège” is a good example of this approach.
“Our partnership with Jazz à Liège began in 2013. It offers the festival the financial support and stability it needs to expand beyond its regional scope, and to achieve its ambitions in terms of quality and diversity”, explains François Fornieri, CEO of Mithra Pharmaceuticals. The benefit of this partnership was apparent during the 2014 edition, notably due to the striking increase in the number of festival-goers (25%), and also due to the presence of must-see names in the jazz world, such as Paolo Conte, Archie Shepp, Paolo Fresu, Kenny Garrett, Kenny Barron and Dave Holland. Like Mithra, Jazz à Liège also uses its pure Liège roots as a springboard for its international ambitions. “The philosophy of the festival, which is namely to make jazz accessible to a larger audience, 100% coincides with our own strategy to make our pharmaceutical solutions accessible to all women throughout the world”.